Dirty mice better recapitulate key features of mRNA vaccine immunogenicity observed in humans

The development of mRNA vaccines during the COVID-19 pandemic dramatically reduced hospitalization and death rates for infected individuals. However, booster vaccinations were required to achieve full efficacy, and protection waned over time. Our research leveraged a "dirty" mouse model to test whether SARS-CoV-2 mRNA vaccinations in animals with previous microbial exposure better modelled human immune responses. We found that dirty mice require a booster vaccination for full efficacy and experienced waning serum antibody titer over time. We propose this approach as a future model for robust preclinical mRNA vaccine testing.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-03-07
DOI
https://doi.org/10.64898/2026.03.07.709392
Primary Topic
Immune responses and vaccinations
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dirty mice better recapitulate key features of mRNA vaccine immunogenicity observed in humans

Ryan A. Langlois, Beatriz Praena, Sneh Lata Gupta, Jens Wrammert et al.
bioRxiv (Cold Spring Harbor Laboratory)
Immune responses and vaccinations
article

Dirty mice better recapitulate key features of mRNA vaccine immunogenicity observed in humans

Ryan A. Langlois, Beatriz Praena, Sneh Lata Gupta, Jens Wrammert, Shanley N. Roach, Frances K. Shepherd, Adam Gilbertsen, Madison Ellis, Devyani Joshi, Cera A. McDonald, Lilin Lai, Carl W. Davis, Mark Pierson, Alberto Moreno
article en

Abstract

The development of mRNA vaccines during the COVID-19 pandemic dramatically reduced hospitalization and death rates for infected individuals. However, booster vaccinations were required to achieve full efficacy, and protection waned over time. Our research leveraged a "dirty" mouse model to test whether SARS-CoV-2 mRNA vaccinations in animals with previous microbial exposure better modelled human immune responses. We found that dirty mice require a booster vaccination for full efficacy and experienced waning serum antibody titer over time. We propose this approach as a future model for robust preclinical mRNA vaccine testing.

bioRxiv (Cold Spring Harbor Laboratory)
University of Minnesota (US), Emory University (US), Children's Healthcare of Atlanta (US), Emory National Primate Research Center
Good health and well-being
Openalex Percentile: Top 28%
Immune responses and vaccinations
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Dirty mice better recapitulate key features of mRNA vaccine immunogenicity observed in humans — Ryan A. Langlois, Beatriz Praena, et al. · bioRxiv (Cold Spring Harbor Laboratory) (2026) | TGRS Research Map | TGRS